Yadanzioside I is primarily studied for its potential antitumor and cytotoxic activities. It has shown inhibitory effects against certain cancer cell lines, making it a subject of interest in anticancer research. The compound may induce apoptosis and suppress cell proliferation, particularly in liver and lung cancer models. Its application is currently limited to preclinical studies, where it serves as a lead compound for developing novel chemotherapeutic agents. Additionally, it contributes to structure-activity relationship studies in natural product chemistry due to its unique triterpenoid saponin structure.